Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

What is Immunochemotherapy?

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Secondary Lung Cancer

What is Tumorigenesis?

Cancer History

Caring for a Loved One with Cancer

Cancer Prognosis

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Screening Considerations: Balancing the Benefits and Risks

Microfluidic cancer treatment screen combined with flow cytometry

See more featured articles »

Cancer Epidemiology

Assay for Monitoring and Treating Malignant Brain Tumors

The Cancer Cell Surface Proteome as a Therapeutic Target

Using Biomarkers to Detect Cancer

Cancer Classification

Hot vs Cold: the differences between tumor types

Cancer Glossary

Insight into Cancer Vaccines

British Pioneers in Cancer Biology

Insights into Oncofertility

Effects of Social and Economic Deprivation on Cancer Mortality

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

What is Cancer of Unknown Primary?

Living with Cancer Pain

Hypoxia Markers and Their Importance

Cancer Management

Cancer Research

Secondary Brain Cancer

Cancer Pain

Is Cancer a Metabolic Disorder?

Overview of Cell Viability and Cytotoxicity

The Effects of Cancer on Family Life

Cancer Prevention: Lowering your Risk

Metastatic Migration in Cancer may be Influenced by Metabolism

Extracellular Vesicles as Floating Cancer Biomarkers

What Causes Cancer?

Exploiting Enzymes in Cancer Diagnosis and Therapy

What is the Tumor Microenvironment?

Cutaneous Manifestations of Internal Malignancy

Investigating the Molecular Mechanisms of Cancer

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

CDK9 and Cancer

Cancer Pathophysiology

TARDIS: The Improved Method of Detecting Breast Cancer

What is Cancer?

Acidosis and Tumor Progression

What is Merkel Cell Carcinoma?

Pediatric Cancer

Cancer Diagnosis

Transforming Cancer Care through Genomic Testing

Cancer Pain Management

Why are Cancer Cell Lines Useful?

Cancer Symptoms

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Targeted Cancer Therapies

Myc Mutations and Cancer

What Role do Biobanks Play in Cancer Research?

The Biochemistry of Breast Cancer Screening

Latest Cancer News and Research

Newly developed radiotheranostic pair identifies and treats renal tumors

A newly developed radiotheranostic pair, 68Ga/177Lu-NYM096, can identify tumors and effectively deliver targeted radiotherapy to patients with metastatic clear cell renal cell carcinoma (ccRCC).

28 Aug 2026

New research questions decades-old assumptions about brain cancer treatment

Australian researchers are challenging decades-old assumptions about brain cancer treatment in a bid to make radiation therapy more effective against tumors, while reducing damage to healthy tissue.

28 Aug 2026

Researchers uncover molecular pathway driving craniosynostosis

Craniosynostosis is a congenital developmental disorder in which the skull's cranial sutures fuse prematurely.

28 Aug 2026

New discovery paves way for highly personalized breast cancer therapies

MYC is a common oncogene that regulates tumor growth and spread, yet no approved drugs exist to target it.

28 Aug 2026

UCSF scientists build largest molecular interaction map for autism

For more than two decades, researchers have identified hundreds of genes that increase the risk of autism spectrum disorder (ASD).

28 Aug 2026

New international guidelines highlight the extensive benefits of cardiac rehabilitation

The European Society of Cardiology (ESC) Guidelines on cardiac rehabilitation have been published online today in the European Heart Journal.

28 Aug 2026

The US switch in shingles vaccines revealed an unexpected heart health pattern

In a natural experiment involving 72,920 propensity-matched US adults aged 60 years and older, recombinant shingles vaccination was associated with a 9% lower cardiovascular disease burden over seven years compared with the live attenuated vaccine. Lower burdens of ischemic heart disease and heart failure were seen in both sexes, while ischemic stroke was significantly lower only among men, supporting further clinical trials and mechanistic studies

27 Aug 2026

Newly identified cells protect lung tumors from immune attacks

Researchers at Columbia University have discovered a new type of cell that protects lung cancers from attacks by the immune system.

27 Aug 2026

Early rasburicase treatment linked to better outcomes in tumor lysis syndrome

Tumor lysis syndrome (TLS) is a life-threatening emergency that occurs when large numbers of cancer cells break down rapidly, releasing substances such as uric acid into the bloodstream that can damage the kidneys and cause serious complications.

27 Aug 2026

$15 million trial aims to improve treatment decisions for older AML patients

A newly funded national clinical trial initiative will gather critical evidence to determine the best treatment strategies for older adults with acute myeloid leukemia (AML), an aggressive, fast-moving blood cancer that leaves a substantial proportion of older patients facing uncertainty about whether to proceed to stem cell transplantation or continue non-transplant therapy.

27 Aug 2026

Study reveals how SGLT2 inhibitors improve failing heart function

Researchers have discovered that SGLT2 inhibitors, a class of drugs originally developed to treat diabetes and now widely used for heart failure, work by activating a key enzyme that helps heart cells produce and use energy more efficiently.

27 Aug 2026

Sunlight, blood sugar and diabetes: a new study finds an intriguing connection

Higher short-term ambient UVA exposure was associated with modestly lower blood glucose levels, particularly during winter, in a large UK Biobank analysis. Separately, more frequent solarium use, used as a proxy for habitual sunlight exposure, was associated with a lower hazard of type 2 diabetes, although the observational findings do not establish causality.

27 Aug 2026

Pomegranate phytobiotics offer natural alternative to synthetic veterinary drugs

Researchers have identified a broad range of biological properties in pomegranate with potential for use in medical applications, including antimicrobial, antiparasitic, antioxidant, immunomodulatory, antidiabetic, anti-inflammatory, liver-supporting, and wound-healing effects.

27 Aug 2026

Unexpected discovery points to a possible route for childhood brain tumor treatments

When researchers at Lund University investigated how the molecule UM171 works, a molecule used to make blood stem cells multiply, they made an unexpected connection.

27 Aug 2026

CAR T-cell therapy successfully reverses severe rheumatoid arthritis

Immunotherapies such as CAR T-cell therapy are used primarily to treat cancer. In the future, these patient-specific therapies, manufactured from patients' own immune cells, could also help cure autoimmune diseases.

27 Aug 2026

Scalable stem cell method advances off-the-shelf CAR-T therapies

Researchers at the Center for Regenerative Medicine (CReM) at Boston Medical Center (BMC) and Boston University (BU) have developed a scalable method for generating CD4+ helper T cells from induced pluripotent stem cells (iPSCs), overcoming a longstanding challenge in the development of stem cell-based immunotherapies.

27 Aug 2026

Unscreened cervical cancer rates rise dangerously over past 20 years

The percentage of women in their 20s who have never been screened for cervical cancer has been increasing at a disturbing rate over the past 20 years – to the point that now, almost a third of women between the ages of 21 and 29 have never been screened.

27 Aug 2026